Acasă › Diabet de tip 1 › Washington
Studii clinice pentru Diabet de tip 1 în Washington
20 studii pentru Diabet de tip 1 caută participanți în Washington.
Orașe în Washington
Text oficial al studiului (în engleză)
Type 1 Diabetes Extension Study
- Benaroya Research Institute, Seattle
În curs de recrutareStudiu observațional
Vârste de la 8 la 35 · Toate sexele · Actualizat 18 sept. 2026 · NCT02734277METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
În curs de recrutareFaza 2
Vârste de la 18 la 69 · Toate sexele · Actualizat 15 sept. 2026 · NCT07699380A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
- MultiCare Mary Bridge Children's Health Center- Site Number : 8400037, Tacoma
În curs de recrutareFaza 3
Vârste de la 1 la 25 · Toate sexele · Actualizat 14 sept. 2026 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
În curs de recrutareFaza 1/2
Vârste de la 12 la 35 · Toate sexele · Actualizat 11 sept. 2026 · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Benaroya Research Institute, Seattle
În curs de recrutareFaza 2
Vârste de la 4 la 34 · Toate sexele · Actualizat 9 sept. 2026 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Benaroya Research Institute, Seattle
În curs de recrutareFaza 2
Vârste de la 8 la 45 · Toate sexele · Actualizat 8 sept. 2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- Seattle Children's Hospital, Seattle
În curs de recrutareFaza 1/2
Vârste de la 9 la 20 · Toate sexele · Actualizat 2 sept. 2026 · NCT07061574SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason, Seattle
- Mary Bridge Children's Outpatient Center - Tacoma, Tacoma
În curs de recrutareFaza 2
Vârste de la 5 la 40 · Toate sexele · Actualizat 24 aug. 2026 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Washington, Seattle
În curs de recrutare
Vârste de la 18 la 65 · Toate sexele · Actualizat 16 iul. 2026 · NCT06880835Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 2 iun. 2026 · NCT05822609Kidney Precision Medicine Project
- University of Washington, Seattle
În curs de recrutareStudiu observațional
Vârste de 18 ani și peste · Toate sexele · Actualizat 14 apr. 2026 · NCT04334707Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
- Rainier Clinical Reseach Center, Renton
În curs de recrutare
Vârste de la 18 la 65 · Toate sexele · Actualizat 9 apr. 2026 · NCT07296276Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
- Rainier Clinical Research Center, Renton
În curs de recrutareFaza 2
Vârste de la 18 la 50 · Toate sexele · Actualizat 6 apr. 2026 · NCT06964087Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
În curs de recrutareFaza 3
Vârste de la 18 la 75 · Toate sexele · Actualizat 24 mar. 2026 · NCT06217302Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
În curs de recrutareFaza 3
Vârste de la 18 la 49 · Toate sexele · Actualizat 4 mar. 2026 · NCT05819138Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
- Seattle Children's, Seattle
În curs de recrutare
Vârste de la 16 la 19 · Toate sexele · Actualizat 30 dec. 2025 · NCT07292558EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
- Benaroya Research Institute, Seattle
În curs de recrutareStudiu observațional
Până la vârsta de 70 · Toate sexele · Actualizat 19 dec. 2025 · NCT03369821InvesT1D: Promoting Adolescent Investment in Diabetes Care
- Seattle Children's, Seattle
În curs de recrutare
Vârste de 12 ani și peste · Toate sexele · Actualizat 16 dec. 2025 · NCT06384911TrialNet Pathway to Prevention of T1D
- Benaroya Research Institute, Seattle
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
Vârste de la 2 la 45 · Toate sexele · Actualizat 1 iul. 2025 · NCT00097292MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
În curs de recrutareFaza 1
Vârste de la 12 la 25 · Toate sexele · Actualizat 13 iun. 2025 · NCT05065372Sursă: ClinicalTrials.gov, date preluate la 3 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.